| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |